Pharmaceuticals giant AstraZeneca is accelerating the shift in its centre of gravity to the US. The move, under chief executive Pascal Soriot, will be a boost for Donald Trump's incoming ...

For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...

Q3 2024 Earnings Call Transcript November 15, 2024 Operator: Hello, and welcome to the AIM ImmunoTech Third Quarter 2024 ...

Follow along for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna about 7% while UK ...

Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...

Health-care companies fell sharply as the selection of Robert F. Kennedy Jr. as Donald Trump's nominee to head the Department of Health and Human Services weighed on vaccine makers. Shares of Pfizer, ...

Fear is spreading across healthcare stocks after news emerged that President-elect Donald Trump will nominate vaccine skeptic ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

RALEIGH, NC. - The Carolina Hurricanes will hold their annual Hockey Fights Cancer awareness game, presented by UNC Health ...

By Samuel Indyk and Ludwig Burger (Reuters) -Shares in global vaccine makers and drugmakers fell on Friday after U.S.

Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and ...